Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Concludes Licensing Agreement With Abbott

NEW YORK, Oct. 4 (GenomeWeb News) - Tm Bioscience has concluded its non-exclusive license agreement with Abbott for certain intellectual property in areas including human and pathogen genotyping, the company said today.

 

The worldwide license expires with the associated patents and "covers Tm's current and future products in all fields of use," the company said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.